US 10188811
Nasal spray device
granted A61KA61K31/57A61K9/0043
Quick answer
US patent 10188811 (Nasal spray device) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Branded Pharmaceutical Products R&D, Inc.
- Grant date
- Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/57, A61K9/0043, A61P, A61P29/00